Indobufen: an updated review of its use in the management of atherothrombosis (Q28184824)

Differential Suppression of Thromboxane Biosynthesis by Indobufen and Aspirin in Patients With Unstable Angina

Europe PubMed Central

title

Indobufen: an updated review of its use in the management of atherothrombosis (English)

0 references

author name string

N Bhana

series ordinal

1

0 references

K J McClellan

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2001

0 references

published in

Drugs & Aging

0 references

volume

18

0 references

issue

5

0 references

page(s)

369-88

0 references

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200118050-00007

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200118050-00007

Fortnightly review: anticoagulation in heart disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200118050-00007

Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.

21 January 2018

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.

1 reference

12 December 2020

Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting

1 reference

12 December 2020

Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

1 reference

12 December 2020

Inhibition of platelet function with indobufen: correlation with plasma drug level

1 reference

12 December 2020

Platelet-active drugs: the relationships among dose, effectiveness, and side effects

1 reference

12 December 2020

Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass

1 reference

12 December 2020

ABC of arterial and venous disease. Secondary prevention of transient ischaemic attack and stroke

1 reference

12 December 2020

Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation

1 reference

12 December 2020

Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis

1 reference

12 December 2020

In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production

1 reference

12 December 2020

A prostacyclin-sparing effect of indobufen vs. aspirin

1 reference

12 December 2020

Pharmacological management of intermittent claudication: a meta-analysis of randomised trials

1 reference

12 December 2020

Thromboprophylaxis for atrial fibrillation

1 reference

12 December 2020

Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months of treatment

1 reference

12 December 2020

Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Preliminary human pharmacology studies on the inhibition of platelet aggregation by indobufen (K 3920)

1 reference

12 December 2020

Efficacy of indobufen in the treatment of intermittent claudication

1 reference

12 December 2020

Effects of short-term treatment with the thromboxane synthesis blocker indobufen on pressor and depressor humoral factors in healthy humans

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

Effect of age on the pharmacokinetics of indobufen

1 reference

12 December 2020

Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man

1 reference

12 December 2020

ABC of arterial and venous disease. Acute stroke

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Antithrombotic effect of indobufen in an experimental model of arterio-arterial microanastomosis in the rat

1 reference

12 December 2020

In vitro and ex vivo effects of indobufen on red blood cell deformability

1 reference

12 December 2020

Antiaggregant effect of indobufen (K3920) measured by the platelet aggregate filtration pressure test (PAFP)

1 reference

12 December 2020

The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man

1 reference

12 December 2020

Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol

1 reference

12 December 2020

Long-term angiographic follow-up of normal and minimally diseased saphenous vein grafts

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.

1 reference

12 December 2020

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

1 reference

12 December 2020

Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction

1 reference

12 December 2020

Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Platelet release reaction and prostaglandin pathway activation in angina patients during exercise: effect of indobufen

1 reference

12 December 2020

Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

12 December 2020

Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole blood

1 reference

12 December 2020

[Prevention of thromboembolism in atrial fibrillation of non-valvular etiology]

1 reference

12 December 2020

Bleeding time and antiplatelet agents in normal volunteers

1 reference

12 December 2020

Atrial fibrillation, thromboembolism and antithrombotic therapy

1 reference

12 December 2020

Long-term evaluation of indobufen in peripheral vascular disease

1 reference

12 December 2020

Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts

1 reference

12 December 2020

Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man

1 reference

12 December 2020

The dispositional enantioselectivity of indobufen in man

1 reference

12 December 2020

Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs

1 reference

12 December 2020

Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication

1 reference

12 December 2020

A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks

1 reference

12 December 2020

Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol

1 reference

12 December 2020

Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease

1 reference

12 December 2020